The Lyme + Cancer Connection: How Surprising Similarities May Revolutionize Treatment
Ever notice how new research on cancer causes and treatments is published every week, whereas studies on chronic Lyme disease are few and far between? That’s in large part because many members of the medical community don’t believe chronic Lyme even exists — a serious problem that’s prolonging the quest for answers.
Now for the encouraging news: Experts are finding striking similarities in how cancer and Lyme disease impact the immune system, which opens up new avenues for targeted Lyme therapies.
The role of pathogens in Lyme disease, cancer, and all chronic illness
- Why the immune system doesn’t recognize chronic infection, and what you can do about it
- New progress on detecting and diagnosing Lyme disease
- Innovative immunotherapies and botanical medicine for treating Lyme disease
- Numerous insights during the live Q&A with Dr. Rawls and Dr. Spector
Presented by Dr. Bill Rawls, Dr. Neil Spector & Carin Gorrell
Wednesday, July 17th
Webinar can be viewed on any device
HAVE A QUESTION?
To learn more about these exciting discoveries and what it means for you, tune in to this live webinar with two physicians who are leading the conversation:
- Dr. Bill Rawls, author of the best-selling book Unlocking Lyme
- Dr. Neil Spector, a cancer researcher and associate professor of medicine at Duke University School of Medicine and author of his memoir, Gone in A Heartbeat: A Physician’s Search for True Healing, on Wednesday, July 17th at 8pm EDT.
Both doctors have the unique perspective of physician-turned-patient: After decades of practicing medicine, severe chronic Lyme symptoms forced Dr. Rawls to put his career in obstetrics/gynecology on hold, and misdiagnosed Lyme ultimately cost Dr. Spector his heart.
From these two doctors who’ve been there, you’ll get new insights into what causes chronic illness, how to avoid it, and new treatment approaches on the horizon. Plus, have your questions ready for a LIVE Q&A with Dr. Rawls and Dr. Spector.